行情

CVM

CVM

CEL SCI
AMEX

实时行情|Nasdaq Last Sale

3.000
-0.040
-1.32%
交易中 14:03 05/24 EDT
开盘
3.000
昨收
3.040
最高
3.070
最低
2.870
成交量
35.20万
成交额
35.99万
52周最高
27.28
52周最低
2.490
市值
1.30亿
市盈率(TTM)
-3.3293
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解CVM最新的财务预测,通过CVM每股收益,每股净资产,每股现金流等数据分析CEL SCI近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测CVM价格均价为15.00,最高价位17.00,最低价为13.00。
最高17.00
均价15.00
最低13.00
现价3.000
EPS
实际EPS
预期EPS
-0.18-0.14-0.09-0.05
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
机构持股
总机构数: 69
机构持股: 585.04万
持股比例: 13.50%
总股本: 4,332.70万
类型机构数股数
增持
19
265.68万
建仓
30
49.35万
减持
4
17.75万
平仓
3
24.38万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
+0.37%
制药与医学研究
-0.12%
高管信息
Chief Executive Officer/Director/Treasurer
Geert Kersten
Senior Vice President/Secretary
Patricia Prichep
Senior Vice President
John Cipriano
Senior Vice President
Daniel Zimmerman
Chief Scientific Officer
Eyal Talor
Independent Director
Bruno Baillavoine
Independent Director
Robert Watson
Independent Director
Peter Young
暂无数据
暂无数据
CVM 简况
CEL-SCI Corp is a clinical-stage biotechnology company. The Company is focused on activating the immune system to fight cancer and infectious diseases. The Company is engaged in research and developing the treatments for the cancer and other diseases by using the immune system. The Company’s lead investigational therapy Multikine (Leukocyte Interleukin, Injection) is in a pivotal Phase 3 clinical trial. Its Multikine is an investigational immunotherapy under development for the potential treatment of certain head and neck cancers. The Company using its Ligand Epitope Antigen Presentation System (LEAPS) technology platform is investigating product candidates include CEL-2000 and CEL-4000. CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis. It is also investigating LEAPS COVID-19 conjugates as a potential treatment of coronavirus (COVID-19) in hospitalized and at-high-risk patients at the University of Georgia’s (UGA) Center.

微牛提供CEL-SCI Corporation(AMEX-CVM)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CVM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CVM股票基本功能。